1-((tetrahydro-2H-pyran-4-yl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

4-(1-Hydroxyethyl)benzamide, 95.0%, 10g

3-Bromo-5-ethoxy-4-hydroxy-benzonitrile, 97.0%, 250mg

N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95.0%, 5g

Methyl 3-amino-4-chloro-1-benzothiophene-2-carboxylate, 95+%, 5g

Methyl 1H-pyrrolo[3,2-c]pyridine-3-carboxylate, 95.0%, 1g

2,6-Dinitrobenzonitrile, 98.0%, 1g

2-Morpholin-4-yl-pyrimidin-4-ol, 95.0%, 250mg

Ethyl 5-(4-bromophenyl)-1,3,4-oxadiazole-2-carboxylate, 97%, 100mg

6-Hydroxypyridazine-3-carboxylic acid, 95.0%, 1g

H-Asn-OtBu, 95%, 1g

5-(thiophen-3-yl)-1H-pyrazole-4-carboxylic acid, 95%, 250mg

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 250mg